LRRK2 Investigative Therapeutics Exchange (LITE)

Part of LRRK2 research is carried out at the CeTPD by the LITE Team, co-supervised by three PIs: Alessio Ciulli, Peter Cossar and Will Farnaby. We are working to accelerate the development of Parkinson’s Disease therapeutics. The mission of this collaboration team is centred on the design, synthesis, evaluation and optimisation of induced-proximity small molecules targeting different regions of Leucine-rich repeat kinase 2 (LRRK2).